Literature DB >> 7485399

Expression of alternatively spliced fibronectin variants during remodeling in proliferative glomerulonephritis.

J L Barnes1, E S Torres, R J Mitchell, J H Peters.   

Abstract

Fibronectin (Fn) plays an important role in tissue remodeling during embryogenesis, wound repair, and vascular disease, and is thought to regulate cellular processes such as cell adhesion, migration, proliferation, and differentiation through specialized domains within the molecule. In addition, Fn can be alternatively spliced at three regions: extradomains EIIIA, EIIIB, and a variable segment V, potentially giving rise to functionally distinct variants of the molecule. We have previously shown a sequential expression of cellular Fn first by platelets, followed by macrophages, then mesangial cells in habu snake venom-induced proliferative glomerulonephritis (Am J Pathol 145: 585-597, 1994). These studies examined the cellular sources and glomerular localization of Fn in general but did not distinguish between the various alternatively spliced isoforms. In this study, we examine by in situ hybridization and immunohistochemistry the temporal expression and cellular sources of EIIIA, EIIIB, and V in a model of proliferation glomerulonephritis that has cell migration, proliferation, and extracellular matrix synthesis as features of tissue remodeling. Macrophages were the first cells to express Fn mRNA showing an EIIIA+, EIIIB-, and V95+ pattern beginning at 8 hours after habu snake venom injection. Migrating mesangial cells at the margins of early lesions (8 and 24 hours) did not overexpress mRNA encoding these Fn variants, but immunofluorescence microscopy revealed V95 and EIIIA protein at the margins of lesions. EIIIB was absent in lesions at this time. At 48 hours and peaking at 72 hours after habu snake venom injection, mesangial cells in central aspects of glomerular lesions expressed abundant mRNA and protein for V95 and EIIIA. EIIIB mRNA and protein was slight in the mesangium at these times. Parietal epithelial cells, particularly adjacent to glomerular lesions, also expressed abundant mRNA and protein for all three variants throughout the course of the disease, beginning at 24 hours after habu snake venom injection. Expression of mRNA and protein for all three isoforms declined by 2 weeks after habu snake venom injection. These studies show that migrating mesangial cells do not require their own synthesis of Fn and suggest that they might rely on exogenous sources of Fn, particularly V95+ and EIIIA+ forms. Commencement of enhanced expression of EIIIA and EIIIB mRNA and protein by resident glomerular cells coincided with the temporal course of cell proliferation, acquisition of alpha-smooth muscle cell actin phenotype, and matrix synthesis, suggesting that Fn isoforms have specific functions during the course of glomerular remodeling.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7485399      PMCID: PMC1869505     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing.

Authors:  L F Brown; D Dubin; L Lavigne; B Logan; H F Dvorak; L Van de Water
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

2.  Different functions of the platelet-derived growth factor-alpha and -beta receptors for the migration and proliferation of cultured baboon smooth muscle cells.

Authors:  N Koyama; C E Hart; A W Clowes
Journal:  Circ Res       Date:  1994-10       Impact factor: 17.367

3.  Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis.

Authors:  T Yamamoto; N A Noble; D E Miller; W A Border
Journal:  Kidney Int       Date:  1994-03       Impact factor: 10.612

4.  Mesangial cell migration precedes proliferation in Habu snake venom-induced glomerular injury.

Authors:  J L Barnes; K A Hevey; R R Hastings; R A Bocanegra
Journal:  Lab Invest       Date:  1994-04       Impact factor: 5.662

5.  TGF-beta 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy.

Authors:  K Tamaki; S Okuda; T Ando; T Iwamoto; M Nakayama; M Fujishima
Journal:  Kidney Int       Date:  1994-02       Impact factor: 10.612

6.  Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in Habu snake venom-induced glomerulonephritis.

Authors:  J L Barnes; H E Abboud
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

7.  Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis.

Authors:  J L Barnes; R R Hastings; M A De la Garza
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

8.  Cholesterol, macrophages, and gene expression of TGF-beta 1 and fibronectin during nephrosis.

Authors:  G Ding; I Pesek-Diamond; J R Diamond
Journal:  Am J Physiol       Date:  1993-04

9.  Expression of the alternatively spliced EIIIB segment of fibronectin.

Authors:  J H Peters; J E Trevithick; P Johnson; R O Hynes
Journal:  Cell Adhes Commun       Date:  1995-02

10.  Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis.

Authors:  W R Jarnagin; D C Rockey; V E Koteliansky; S S Wang; D M Bissell
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

View more
  10 in total

1.  Expression of fibronectin splicing variants in organ transplantation: a differential pattern between rat cardiac allografts and isografts.

Authors:  A J Coito; L F Brown; J H Peters; J W Kupiec-Weglinski; L van de Water
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis.

Authors:  Jennifer L Faulkner; Lisa M Szcykalski; Fredyne Springer; Jeffrey L Barnes
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

Review 3.  Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects.

Authors:  H Kosmehl; A Berndt; D Katenkamp
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

4.  Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders.

Authors:  Linda L Bachinski; Mario Sirito; Maria Böhme; Keith A Baggerly; Bjarne Udd; Ralf Krahe
Journal:  Muscle Nerve       Date:  2010-12       Impact factor: 3.217

Review 5.  Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases.

Authors:  Jeffrey L Barnes; Yves Gorin
Journal:  Kidney Int       Date:  2011-02-09       Impact factor: 10.612

6.  NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts.

Authors:  Corry D Bondi; Nagaraj Manickam; Duck Yoon Lee; Karen Block; Yves Gorin; Hanna E Abboud; Jeffrey L Barnes
Journal:  J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 10.121

7.  Important role for fibronectin-EIIIA during renal tubular repair and cellular recovery in uranyl acetate-induced acute renal failure of rats.

Authors:  Taiki Fujimoto; Yoshihide Fujigaki; Di Fei Sun; Akashi Togawa; Katsuhiko Yonemura; Akira Hishida
Journal:  Virchows Arch       Date:  2003-07-17       Impact factor: 4.064

8.  Renal tubular cell injury and fibronectin.

Authors:  Masao Tsujihata; Osamu Miyake; Kazuhiro Yoshimura; Kozo Tsujikawa; Norihide Tei; Akihiko Okuyama
Journal:  Urol Res       Date:  2003-09-13

9.  Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma.

Authors:  H Kosmehl; A Berndt; S Strassburger; L Borsi; P Rousselle; U Mandel; P Hyckel; L Zardi; D Katenkamp
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

10.  CCL18 synergises with high concentrations of glucose in stimulating fibronectin production in human renal tubuloepithelial cells.

Authors:  Rosa M Montero; Gurjeet Bhangal; Charles D Pusey; Andrew H Frankel; Frederick W K Tam
Journal:  BMC Nephrol       Date:  2016-09-29       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.